Detailed information for compound 146658

Basic information

Technical information
  • TDR Targets ID: 146658
  • Name: (1S,2R,5S)-1-N-hydroxy-2-(2-methylpropyl)-3,1 1-dioxo-5-N-[[(2R)-oxolan-2-yl]methyl]-12-oxa -4,10-diazacyclopentadecane-1,5-dicarboxamide
  • MW: 484.586 | Formula: C23H40N4O7
  • H donors: 5 H acceptors: 5 LogP: 1.05 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: ONC(=O)[C@H]1CCCOC(=O)NCCCC[C@H](NC(=O)[C@@H]1CC(C)C)C(=O)NC[C@H]1CCCO1
  • InChi: 1S/C23H40N4O7/c1-15(2)13-18-17(21(29)27-32)8-6-12-34-23(31)24-10-4-3-9-19(26-20(18)28)22(30)25-14-16-7-5-11-33-16/h15-19,32H,3-14H2,1-2H3,(H,24,31)(H,25,30)(H,26,28)(H,27,29)/t16-,17+,18-,19+/m1/s1
  • InChiKey: BLOFXBALQSQAJS-HCXYKTFWSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • (1S,4R,5S)-5-(hydroxycarbamoyl)-4-isobutyl-3,10-dioxo-N-[[(2R)-tetrahydrofuran-2-yl]methyl]-9-oxa-2,11-diazacyclopentadecane-1-carboxamide
  • (1S,4R,5S)-5-[(hydroxyamino)-oxomethyl]-4-isobutyl-3,10-dioxo-N-[[(2R)-2-tetrahydrofuranyl]methyl]-9-oxa-2,11-diazacyclopentadecane-1-carboxamide
  • (1S,2R,5S)-N1-hydroxy-2-(2-methylpropyl)-3,11-dioxo-N5-[[(2R)-oxolan-2-yl]methyl]-12-oxa-4,10-diazacyclopentadecane-1,5-dicarboxamide
  • (1S,4R,5S)-5-(hydroxycarbamoyl)-4-isobutyl-3,10-diketo-N-[[(2R)-tetrahydrofuran-2-yl]methyl]-9-oxa-2,11-diazacyclopentadecane-1-carboxamide
  • (8S,11R,12S)-N'-hydroxy-11-(2-methylpropyl)-2,10-dioxo-N-[[(2R)-oxolan-2-yl]methyl]-1-oxa-3,9-diazacyclopentadecane-8,12-dicarboxamide
  • (8S,11R,12S)-12-(hydroxycarbamoyl)-11-isobutyl-2,10-dioxo-N-[[(2R)-tetrahydrofuran-2-yl]methyl]-1-oxa-3,9-diazacyclopentadecane-8-carboxamide
  • (8S,11R,12S)-12-[(hydroxyamino)-oxomethyl]-11-isobutyl-2,10-dioxo-N-[[(2R)-2-tetrahydrofuranyl]methyl]-1-oxa-3,9-diazacyclopentadecane-8-carboxamide
  • (8S,11R,12S)-12-(hydroxycarbamoyl)-11-isobutyl-2,10-diketo-N-(tetrahydrofurfuryl)-1-oxa-3,9-diazacyclopentadecane-8-carboxamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ADAM metallopeptidase domain 17 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis adam 17 protease Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus multilocularis Blood coagulation inhibitor, Disintegrin Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus granulosus adam 17 protease Get druggable targets OG5_132656 All targets in OG5_132656
Schistosoma mansoni ADAM17 peptidase (M12 family) Get druggable targets OG5_132656 All targets in OG5_132656
Schistosoma japonicum ko:K06059 a disintegrin and metalloproteinase domain 17, putative Get druggable targets OG5_132656 All targets in OG5_132656
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132656 All targets in OG5_132656
Echinococcus granulosus Blood coagulation inhibitor Disintegrin Get druggable targets OG5_132656 All targets in OG5_132656
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Disintegrin family protein ADAM metallopeptidase domain 17 824 aa 724 aa 27.4 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0129 0.065 0.0531
Echinococcus granulosus Blood coagulation inhibitor Disintegrin 0.014 0.0953 0.2474
Schistosoma mansoni hypothetical protein 0.0129 0.065 0.2007
Echinococcus multilocularis Blood coagulation inhibitor, Disintegrin 0.014 0.0953 0.2942
Schistosoma mansoni hypothetical protein 0.0191 0.2355 0.7269
Echinococcus granulosus geminin 0.0191 0.2355 0.6114
Brugia malayi Cell division protein ftsZ 0.0175 0.1931 1
Plasmodium vivax cysteine repeat modular protein 1, putative 0.0129 0.065 0.5
Brugia malayi Calcitonin receptor-like protein seb-1 0.011 0.0126 0.0651
Treponema pallidum cell division protein FtsZ 0.0355 0.6887 0.5
Plasmodium falciparum cysteine repeat modular protein 1 0.0129 0.065 0.5
Schistosoma mansoni ADAM17 peptidase (M12 family) 0.0223 0.324 1
Echinococcus granulosus adam 17 protease 0.0245 0.3852 1
Mycobacterium ulcerans cell division protein FtsZ 0.0355 0.6887 0.5
Brugia malayi Protein kinase domain containing protein 0.0129 0.065 0.3366
Mycobacterium leprae cell division protein FtsZ 0.0355 0.6887 0.5
Echinococcus granulosus tissue type plasminogen activator 0.0129 0.065 0.1688
Leishmania major hypothetical protein, conserved 0.0129 0.065 0.5
Toxoplasma gondii kringle domain-containing protein 0.0129 0.065 0.5
Mycobacterium tuberculosis Cell division protein FtsZ 0.0355 0.6887 0.5
Echinococcus multilocularis geminin 0.0191 0.2355 0.7269
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.011 0.0126 0.0651
Onchocerca volvulus 0.0129 0.065 0.5
Schistosoma mansoni hypothetical protein 0.0191 0.2355 0.7269
Brugia malayi Cell division protein ftsZ 0.017 0.1796 0.9302
Trypanosoma cruzi hypothetical protein, conserved 0.0129 0.065 0.5
Loa Loa (eye worm) TK/ROR protein kinase 0.0129 0.065 0.0531
Wolbachia endosymbiont of Brugia malayi cell division protein FtsZ 0.0355 0.6887 0.5
Echinococcus multilocularis tissue type plasminogen activator 0.0129 0.065 0.2007
Echinococcus multilocularis adam 17 protease 0.0223 0.324 1
Brugia malayi Kringle domain containing protein 0.0129 0.065 0.3366

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 0.98 uM Inhibition of LPS-stimulated TNF-alpha release in human whole blood ChEMBL. 11472217
IC50 (functional) = 0.98 uM Inhibition of LPS-stimulated TNF-alpha release in human whole blood ChEMBL. 11472217

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.